Key result
A past history of cardiovascular disease was a strong independent risk factor for left ventricular hypertrophy in Japanese patients with stage 3-5 chronic kidney disease, alongside higher BMI, systolic blood pressure, and urinary albumin.
Cross-Sectional (n=1,088)
Yes
Answers are grounded in this paper and cite their sources.
In patients with stage 3-5 CKD, past history of cardiovascular disease, higher BMI, higher systolic blood pressure, higher urinary albumin, and lower serum total cholesterol are independent risk factors for left ventricular hypertrophy.
BACKGROUND: Although left ventricular hypertrophy (LVH) has been established as a predictor of cardiovascular events in chronic kidney disease (CKD), the relationship between the prevalence of LVH and CKD stage during the pre-dialysis period has not been fully examined. METHODS: We measured left ventricular mass index (LVMI) in a cross-sectional cohort of participants in the Chronic Kidney Disease Japan Cohort (CKD-JAC) study to identify factors that are associated with increased LVMI in patients with stage 3-5 CKD. RESULTS: We analyzed the baseline characteristics in 1088 participants (male 63.8%, female 36.2%). Diabetes mellitus was the underlying disease in 41.7% of the patients, and mean age was 61.8 ± 11.1 years. LVH was detected in 23.4% of the patients at baseline. By multivariate logistic analysis, independent risk factors for LVH were past history of cardiovascular disease [odds ratio (OR) 2.364; 95% confidence interval ([CI) 1.463-3.822; P = 0.0004], body mass index (OR 1.108; 95% CI 1.046-1.173; P = 0.0005), systolic blood pressure (OR 1.173; 95% CI 1.005-1.369; P = 0.0433), urinary albumin (OR 1.425; 95% CI 1.028-1.974; P = 0.0333), and serum total cholesterol level (OR 0.994; 95% CI 0.989-0.999; P = 0.0174). CONCLUSION: The cross-sectional baseline data from the CKD-JAC study shed light on the association between LVH and risk factors in patients with decreased renal function. Further longitudinal analyses of the CKD-JAC cohort are needed to evaluate the prognostic value of LVH in CKD patients.
No takes yet. Share an insight, caveat, or question.
Nitta et al. (2018) conducted a cross-sectional in Chronic kidney disease (stage 3-5) (n=1,088). Past history of cardiovascular disease vs. No past history of cardiovascular disease was evaluated on Left ventricular hypertrophy (LVH) (OR 2.364, 95% CI 1.463-3.822, p=0.0004). A past history of cardiovascular disease was a strong independent risk factor for left ventricular hypertrophy in Japanese patients with stage 3-5 chronic kidney disease, alongside higher BMI, systolic blood pressure, and urinary albumin.
Synapse has enriched 10 related papers. Consider them for comparative context: